cfr_sections: 21:21:6.0.1.1.11.0.1.118
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| section_id | title_number | title_name | chapter | subchapter | part_number | part_name | subpart | subpart_name | section_number | section_heading | agency | authority | source_citation | amendment_citations | full_text |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21:21:6.0.1.1.11.0.1.118 | 21 | Food and Drugs | I | E | 520 | PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS | 520.1084 | § 520.1084 Grapiprant. | FDA | 21 U.S.C. 360b. | 40 FR 13838, Mar. 27, 1975, unless otherwise noted. | [81 FR 36789, June 8, 2016, as amended at 83 FR 14587, Apr. 5, 2018] | (a) Specifications. Each tablet contains 20, 60, or 100 milligrams (mg) grapiprant. (b) Sponsor. See No. 058198 in § 510.600(c) of this chapter. (c) Conditions of use in dogs —(1) Amount. Administer 0.9 mg/lb (2 mg/kg) once daily by mouth. (2) Indications for use. For the control of pain and inflammation associated with osteoarthritis in dogs. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |